ATE337396T1 - Kombinatorische bibliotheken heteromerer cytotoxischer proteine - Google Patents

Kombinatorische bibliotheken heteromerer cytotoxischer proteine

Info

Publication number
ATE337396T1
ATE337396T1 AT98959689T AT98959689T ATE337396T1 AT E337396 T1 ATE337396 T1 AT E337396T1 AT 98959689 T AT98959689 T AT 98959689T AT 98959689 T AT98959689 T AT 98959689T AT E337396 T1 ATE337396 T1 AT E337396T1
Authority
AT
Austria
Prior art keywords
heteromeric
proteins
cytotoxic proteins
target cell
combinatory libraries
Prior art date
Application number
AT98959689T
Other languages
English (en)
Inventor
Jean Gariepy
Mark Robert Bray
Original Assignee
Univ Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network filed Critical Univ Health Network
Application granted granted Critical
Publication of ATE337396T1 publication Critical patent/ATE337396T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT98959689T 1998-02-04 1998-12-08 Kombinatorische bibliotheken heteromerer cytotoxischer proteine ATE337396T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002222993A CA2222993A1 (en) 1998-02-04 1998-02-04 A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries

Publications (1)

Publication Number Publication Date
ATE337396T1 true ATE337396T1 (de) 2006-09-15

Family

ID=4161822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959689T ATE337396T1 (de) 1998-02-04 1998-12-08 Kombinatorische bibliotheken heteromerer cytotoxischer proteine

Country Status (8)

Country Link
US (1) US7713915B1 (de)
EP (1) EP1051482B1 (de)
JP (1) JP4339511B2 (de)
AT (1) ATE337396T1 (de)
AU (1) AU769824B2 (de)
CA (1) CA2222993A1 (de)
DE (1) DE69835695T2 (de)
WO (1) WO1999040185A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE467641T1 (de) * 2004-03-26 2010-05-15 Molecular Templates Inc Bibliothek von toxin mutanten und deren verwendung
CA2664549A1 (en) * 2005-09-26 2007-03-29 University Health Network Library from toxin mutants, and methods of using same
US20100298238A1 (en) * 2007-10-08 2010-11-25 Rutgers, The State University Nontoxic shiga-like toxin mutant compositions and methods
CN104854455B (zh) * 2012-12-04 2017-10-27 台湾神隆股份有限公司 筛选分子群的方法
CN111363047A (zh) 2013-03-12 2020-07-03 分子模板公司 用于引起细胞内化的cd20结合免疫毒素及其使用方法
ES2749862T3 (es) 2014-01-27 2020-03-24 Molecular Templates Inc Polipéptidos efectores desinmunizados de subunidad A de toxina Shiga para aplicaciones en mamíferos
JP6814634B2 (ja) * 2014-02-05 2021-01-20 モレキュラー テンプレーツ, インク.Molecular Templates, Inc. リボ毒性の一時的な減少に基づき、細胞毒性組換えポリペプチドをスクリーニングし、選択し、同定する方法
US11142584B2 (en) 2014-03-11 2021-10-12 Molecular Templates, Inc. CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
KR102496206B1 (ko) 2014-06-11 2023-02-06 몰레큘러 템플레이츠, 인코퍼레이션. 프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
WO2016126950A1 (en) * 2015-02-05 2016-08-11 Molecular Templates, Inc. Multivalent cd20-binding molecules comprising shiga toxin a subunit effector regions and enriched compositions thereof
CN114656573B (zh) 2015-05-30 2024-09-27 分子模板公司 去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
MX2018001208A (es) 2015-07-26 2018-03-26 Molecular Templates Inc Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+.
MX2019006656A (es) 2016-12-07 2019-09-09 Molecular Templates Inc Polipeptidos efectores de la sub-unidad a de la toxina shiga andamiajes de los efectores de la toxina shiga y moleculas con direccion hacia las celulas para la conjugacion especifica del sitio.
KR102590672B1 (ko) 2017-01-25 2023-10-18 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
KR20200143634A (ko) 2018-04-17 2020-12-24 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 스캐폴드를 포함하는 her2-표적화 분자

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5047513A (en) 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB9109478D0 (en) * 1991-05-02 1991-06-26 Therapeutic Antibodies Inc Antivenoms
DE69233035D1 (de) * 1991-12-24 2003-06-05 Harvard College Gezielte punkt-mutagenese von dna
US5659123A (en) * 1994-08-26 1997-08-19 Plant Genetic Systems, N.V. Diabrotica toxins
US5869250A (en) * 1996-12-02 1999-02-09 The University Of North Carolina At Chapel Hill Method for the identification of peptides that recognize specific DNA sequences
US6086900A (en) 1997-03-26 2000-07-11 Board Of Regents, The University Of Texas Systems Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes
US5888750A (en) 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
US20020161203A1 (en) * 2000-08-14 2002-10-31 Sheppard Paul O. Rattlesnake venom gland proteins
US20030188326A1 (en) * 2000-11-03 2003-10-02 Dana Farber Cancer Institute Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

Also Published As

Publication number Publication date
US7713915B1 (en) 2010-05-11
WO1999040185A1 (en) 1999-08-12
CA2222993A1 (en) 1999-08-04
AU769824B2 (en) 2004-02-05
EP1051482B1 (de) 2006-08-23
JP4339511B2 (ja) 2009-10-07
JP2002503453A (ja) 2002-02-05
DE69835695T2 (de) 2007-08-23
DE69835695D1 (de) 2006-10-05
AU1553099A (en) 1999-08-23
EP1051482A1 (de) 2000-11-15

Similar Documents

Publication Publication Date Title
DE69835695D1 (de) Kombinatorische bibliotheken heteromerer cytotoxischer proteine
Seyedsayamdost et al. Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4
LU91759I2 (fr) Denosumab et ses dérivés pharmaceutique acceptables (PROLIA®)
AU1548795A (en) Bacterial receptor structures
EP1075513B8 (de) Kontinuierliche in vitro-evolution.
Chehade et al. Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DE602004011770D1 (de) Fusionsproteine
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
DE69434166D1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
UA32548C2 (uk) Ізольована послідовність днк, що кодує epsps фермент, ізольована послідовність днк, що кодує білок, який виявляє epsps активність, рекомбінантна двониткова молекула днк, спосіб одержання генетично трансформованих рослин
NO20002787L (no) Nye forbindelser
ES2174075T3 (es) Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas.
PT850310E (pt) Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica
EA200000109A1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
DK0745124T3 (da) Pattedyr-cellecyklusprotein
NO20021686D0 (no) Fremgangsmåter for fremstilling av målemolekyler i et transgent dyr og rensing av målmolekylet
ATE211174T1 (de) Thymidin-kinase-mutanten
Rothman et al. General method for the synthesis of caged phosphopeptides: tools for the exploration of signal transduction pathways
EP1272609A4 (de) Einkettige antikörper gegen eine p53 mutante
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
WO1996031603A3 (en) Methods and compositions for regulating fadd
BR0100164A (pt) Modelos de farmacóforo, métodos de rastreio e identificação da potência inibidora de citocromo p-450 de antagonistas do receptor neuroquinina-1
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties